These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 32003036)

  • 1. Structural binding interactions of tetrabromobisphenol A with sex steroid nuclear receptors and sex hormone-binding globulin.
    Sheikh IA; Beg MA
    J Appl Toxicol; 2020 Jun; 40(6):832-842. PubMed ID: 32003036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human sex hormone-binding globulin binding affinities of 125 structurally diverse chemicals and comparison with their binding to androgen receptor, estrogen receptor, and α-fetoprotein.
    Hong H; Branham WS; Ng HW; Moland CL; Dial SL; Fang H; Perkins R; Sheehan D; Tong W
    Toxicol Sci; 2015 Feb; 143(2):333-48. PubMed ID: 25349334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of tetrabromobisphenol A effects on human glucocorticoid and androgen receptors: A comparison of results from human- with yeast-based in vitro assays.
    Beck KR; Sommer TJ; Schuster D; Odermatt A
    Toxicology; 2016 Aug; 370():70-77. PubMed ID: 27693315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallel biotransformation of tetrabromobisphenol A in Xenopus laevis and mammals: Xenopus as a model for endocrine perturbation studies.
    Fini JB; Riu A; Debrauwer L; Hillenweck A; Le Mével S; Chevolleau S; Boulahtouf A; Palmier K; Balaguer P; Cravedi JP; Demeneix BA; Zalko D
    Toxicol Sci; 2012 Feb; 125(2):359-67. PubMed ID: 22086976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding and Activity of Tetrabromobisphenol A Mono-Ether Structural Analogs to Thyroid Hormone Transport Proteins and Receptors.
    Ren XM; Yao L; Xue Q; Shi J; Zhang Q; Wang P; Fu J; Zhang A; Qu G; Jiang G
    Environ Health Perspect; 2020 Oct; 128(10):107008. PubMed ID: 33095664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brominated flame retardants, hexabromocyclododecane and tetrabromobisphenol A, affect proinflammatory protein expression in human bronchial epithelial cells via disruption of intracellular signaling.
    Koike E; Yanagisawa R; Takano H
    Toxicol In Vitro; 2016 Apr; 32():212-9. PubMed ID: 26718265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the interactions of decabrominateddiphenyl ether and tetrabromobisphenol A with human serum albumin.
    Wang YQ; Zhang HM; Cao J
    Environ Toxicol Pharmacol; 2014 Sep; 38(2):595-606. PubMed ID: 25194328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of novel ligands of ERα, Erβ, and PPARγ: the case of halogenated bisphenol A and their conjugated metabolites.
    Riu A; le Maire A; Grimaldi M; Audebert M; Hillenweck A; Bourguet W; Balaguer P; Zalko D
    Toxicol Sci; 2011 Aug; 122(2):372-82. PubMed ID: 21622942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor γ is a target for halogenated analogs of bisphenol A.
    Riu A; Grimaldi M; le Maire A; Bey G; Phillips K; Boulahtouf A; Perdu E; Zalko D; Bourguet W; Balaguer P
    Environ Health Perspect; 2011 Sep; 119(9):1227-32. PubMed ID: 21561829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrabromobisphenol A induced reproductive endocrine-disrupting effects in mussel Mytilus galloprovincialis.
    Wang S; Ji C; Li F; Zhan J; Sun T; Tang J; Wu H
    J Hazard Mater; 2021 Aug; 416():126228. PubMed ID: 34492982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrabromobisphenol-A disrupts thyroid hormone receptor alpha function in vitro: use of fluorescence polarization to assay corepressor and coactivator peptide binding.
    Lévy-Bimbot M; Major G; Courilleau D; Blondeau JP; Lévi Y
    Chemosphere; 2012 May; 87(7):782-8. PubMed ID: 22277881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular interactions of vinclozolin metabolites with human estrogen receptors 1GWR-α and 1QKM and androgen receptor 2AM9-β: Implication for endocrine disruption.
    Habib H; Haider MR; Sharma S; Ahmad S; Dabeer S; Yar MS; Raisuddin S
    Toxicol Mech Methods; 2020 Jun; 30(5):370-377. PubMed ID: 32208804
    [No Abstract]   [Full Text] [Related]  

  • 13. Biotransformation of the flame retardant tetrabromobisphenol-A (TBBPA) by freshwater microalgae.
    Peng FQ; Ying GG; Yang B; Liu YS; Lai HJ; Zhou GJ; Chen J; Zhao JL
    Environ Toxicol Chem; 2014 Aug; 33(8):1705-11. PubMed ID: 24687216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural binding perspectives of common plasticizers and a flame retardant, BDE-153, against thyroxine-binding globulin: potential for endocrine disruption.
    Sheikh IA; Beg MA
    J Appl Toxicol; 2022 May; 42(5):841-851. PubMed ID: 34725837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TBBPA downregulates thyroid receptor and estrogen receptor mRNA levels in goldfish gonadal tissue.
    Maur G; Edwards B; Habibi HR; Allan ERO
    Anim Reprod Sci; 2022 May; 240():106990. PubMed ID: 35537367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicogenomic analysis of the ability of brominated flame retardants TBBPA and BDE-209 to disrupt thyroid hormone signaling in neural cells.
    Guyot R; Chatonnet F; Gillet B; Hughes S; Flamant F
    Toxicology; 2014 Nov; 325():125-32. PubMed ID: 25172293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing oestrogenic effects of brominated flame retardants hexabromocyclododecane and tetrabromobisphenol A on MCF-7 cells.
    Dorosh A; Děd L; Elzeinová F; Pěknicová J
    Folia Biol (Praha); 2011; 57(1):35-9. PubMed ID: 21457653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrethroids and reproductive function: some endocrine disrupting perspectives from molecular simulations.
    Sheikh IA; Beg MA; Macha MA
    Ecotoxicology; 2024 Nov; 33(9):1086-1095. PubMed ID: 39214921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high dose mode of action for tetrabromobisphenol A-induced uterine adenocarcinomas in Wistar Han rats: A critical evaluation of key events in an adverse outcome pathway framework.
    Wikoff DS; Rager JE; Haws LC; Borghoff SJ
    Regul Toxicol Pharmacol; 2016 Jun; 77():143-59. PubMed ID: 26828025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroids and endocrine disruptors--History, recent state of art and open questions.
    Hampl R; Kubátová J; Stárka L
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt B):217-23. PubMed ID: 24816231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.